Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 12664
Country/Region: Kenya
Year: 2014
Main Partner: Amref Health Africa
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,349,245 Additional Pipeline Funding: $755

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Africa Medical Research Foundation’s (AMREF) goal is to implement high quality prevention, care, and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections in the Kibera slums where the HIV prevalence is almost twice the national average. Kibera slum is within Nairobi County, Kenya with an estimated population of 170,000. AMREF will reach this population with both facility based and community based services including HTC, Linkage and Enrollment to ART care, PMTCT and HIV/AIDS Health education to the Kibera residents.

Cost efficiency is addressed through integration of services, use of existing evidence-based efficient strategies, task shifting, implementing more facility-based training and mentorship as opposed to offsite training, cost effective strategies for defaulter management and laboratory networking.

AMREF is closely working with the government, local community based organizations and community members in project implementation in ensuring that project activities are well coordinated and in line with the governments priorities. AMREF will continue to monitor all project activities and report all required indicators to PEPFAR and the Ministry of Health (MOH), performance will be tracked regularly and reports generated will also be discussed by the team to inform programming. AMREF will also adopt Kenya’s’ HIV quality framework to improve clinical outcomes.

AMREF is working closely with the MOH and the Sub County Health Management Team and plans to eventually hand over the facilities to the government. AMREF will continue to offer technical support to MoH and Sub counties.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $194,739
Care: TB/HIV (HVTB) $83,476
Care: Pediatric Care and Support (PDCS) $39,964
Testing: HIV Testing and Counseling (HVCT) $75,369
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $226,230
Treatment: Adult Treatment (HTXS) $689,828
Treatment: Pediatric Treatment (PDTX) $39,639
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 386
C2.1.D By Age: 15+ 2015 3,895
C2.1.D By Age/Sex: <15 Female 2015 193
C2.1.D By Age/Sex: <15 Male 2015 193
C2.1.D By Age/Sex: 15+ Female 2015 2,571
C2.1.D By Age/Sex: 15+ Male 2015 1,324
C2.1.D By Sex: Female 2015 2,764
C2.1.D By Sex: Male 2015 1,517
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 4,281
C2.1.D Sum of Age disaggregates 2015 4,281
C2.1.D Sum of Age/Sex disaggregates 2015 4,281
C2.1.D Sum of Sex disaggregates 2015 4,281
C2.1.D_NGI By Age: <15 2015 386
C2.1.D_NGI By Age: 15+ 2015 3,895
C2.1.D_NGI By Age/Sex: <15 Female 2015 193
C2.1.D_NGI By Age/Sex: <15 Male 2015 193
C2.1.D_NGI By Age/Sex: 15+ Female 2015 2,571
C2.1.D_NGI By Age/Sex: 15+ Male 2015 1,324
C2.1.D_NGI By Sex: Female 2015 2,764
C2.1.D_NGI By Sex: Male 2015 1,517
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 4,281
C2.1.D_NGI Sum of Age disaggregates 2015 4,281
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 4,281
C2.1.D_NGI Sum of Sex disaggregates 2015 4,281
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 4,281
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 4,067
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 4,281
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 81
CARE_CURR Age/sex: <1 Female 2015 6
CARE_CURR Age/sex: <1 Male 2015 6
CARE_CURR Age/sex: 1-4 Female 2015 42
CARE_CURR Age/sex: 1-4 Male 2015 44
CARE_CURR Age/sex: 10-14 Female 2015 58
CARE_CURR Age/sex: 10-14 Male 2015 59
CARE_CURR Age/sex: 15-19 Female 2015 52
CARE_CURR Age/sex: 15-19 Male 2015 31
CARE_CURR Age/sex: 20-24 Female 2015 214
CARE_CURR Age/sex: 20-24 Male 2015 58
CARE_CURR Age/sex: 25-49 Female 2015 1,826
CARE_CURR Age/sex: 25-49 Male 2015 869
CARE_CURR Age/sex: 5-9 Female 2015 77
CARE_CURR Age/sex: 5-9 Male 2015 74
CARE_CURR Age/sex: 50+ Female 2015 351
CARE_CURR Age/sex: 50+ Male 2015 300
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 183
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 183
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 2,443
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 1,258
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 4,067
CARE_CURR Sum of Age/Sex disaggregates 2015 4,067
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 4,067
CARE_NEW Age/sex: <1 Female 2015 2
CARE_NEW Age/sex: <1 Male 2015 1
CARE_NEW Age/sex: 1-4 Female 2015 7
CARE_NEW Age/sex: 1-4 Male 2015 8
CARE_NEW Age/sex: 10-14 Female 2015 11
CARE_NEW Age/sex: 10-14 Male 2015 10
CARE_NEW Age/sex: 15-19 Female 2015 11
CARE_NEW Age/sex: 15-19 Male 2015 5
CARE_NEW Age/sex: 20-24 Female 2015 20
CARE_NEW Age/sex: 20-24 Male 2015 20
CARE_NEW Age/sex: 25-49 Female 2015 307
CARE_NEW Age/sex: 25-49 Male 2015 172
CARE_NEW Age/sex: 5-9 Female 2015 13
CARE_NEW Age/sex: 5-9 Male 2015 14
CARE_NEW Age/sex: 50+ Female 2015 106
CARE_NEW Age/sex: 50+ Male 2015 32
CARE_NEW Aggregated Age/sex: <15 Female 2015 33
CARE_NEW Aggregated Age/sex: <15 Male 2015 33
CARE_NEW Aggregated Age/sex: 15+ Female 2015 444
CARE_NEW Aggregated Age/sex: 15+ Male 2015 229
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 739
CARE_NEW Sum of Age/sex disaggregates 2015 739
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 739
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 4
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 4
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 4
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 4
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 4
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 4
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 4
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 4
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 4
FN_SITE Sum of Numerator Support Type disaggregates 2015 4
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 4
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 4
FN_THER Age: <1 2015 2
FN_THER Age: 1-4 2015 14
FN_THER Age: 15-17 2015 13
FN_THER Age: 18+ 2015 570
FN_THER Age: 5-14 2015 43
FN_THER Aggregated Age: <18 2015 72
FN_THER Aggregated Age: 18+ 2015 570
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 642
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 856
FN_THER Sum of Age disaggregates 2015 642
FN_THER Sum of Aggregated Age disaggregates 2015 642
FPINT_SITE By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 3
FPINT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points 2015 4
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 3
FPINT_SITE Service delivery type: Clinical 2015 3
FPINT_SITE Sum of Numerator Site Support Type disaggregates 2015 3
FPINT_SITE Sum of Service Delivery Type disaggregates 2015 3
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 4
FPINT_SITE_den Sum of Denominator Site Support Type disaggregates 2015 4
HTS_TST Age/sex: 1-4 Female 2015 879
HTS_TST Age/sex: 1-4 Female 2015 879
HTS_TST Age/sex: 1-4 Male 2015 879
HTS_TST Age/sex: 1-4 Male 2015 879
HTS_TST Age/sex: 10-14 Female 2015 628
HTS_TST Age/sex: 10-14 Female 2015 628
HTS_TST Age/sex: 10-14 Male 2015 628
HTS_TST Age/sex: 10-14 Male 2015 628
HTS_TST Age/sex: 15-19 Female 2015 1,256
HTS_TST Age/sex: 15-19 Female 2015 1,256
HTS_TST Age/sex: 15-19 Male 2015 1,256
HTS_TST Age/sex: 15-19 Male 2015 1,256
HTS_TST Age/sex: 20-24 Female 2015 3,140
HTS_TST Age/sex: 20-24 Female 2015 3,140
HTS_TST Age/sex: 20-24 Male 2015 3,140
HTS_TST Age/sex: 20-24 Male 2015 3,140
HTS_TST Age/sex: 25-49 Female 2015 5,025
HTS_TST Age/sex: 25-49 Female 2015 5,025
HTS_TST Age/sex: 25-49 Male 2015 5,025
HTS_TST Age/sex: 25-49 Male 2015 5,025
HTS_TST Age/sex: 5-9 Female 2015 377
HTS_TST Age/sex: 5-9 Female 2015 377
HTS_TST Age/sex: 5-9 Male 2015 377
HTS_TST Age/sex: 5-9 Male 2015 377
HTS_TST Age/sex: 50+ Female 2015 1,257
HTS_TST Age/sex: 50+ Female 2015 1,257
HTS_TST Age/sex: 50+ Male 2015 1,256
HTS_TST Age/sex: 50+ Male 2015 1,256
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,884
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 1,884
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 10,678
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 10,677
HTS_TST Aggregated Age/sex: <15 Female 2015 1,884
HTS_TST Aggregated Age/sex: <15 Male 2015 1,884
HTS_TST Aggregated Age/sex: 15+ Female 2015 10,678
HTS_TST Aggregated Age/sex: 15+ Male 2015 10,677
HTS_TST By Test Result: Negative 2015 24,118
HTS_TST By Test Result: Negative 2015 24,118
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 25,123
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 25,123
HTS_TST Sum of Age/Sex disaggregates 2015 25,123
HTS_TST Sum of Age/Sex disaggregates 2015 25,123
HTS_TST Sum of Aggregated Age/Sex <15 2015 3,768
HTS_TST Sum of Aggregated Age/Sex <15 2015 3,768
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 21,355
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 21,355
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 25,123
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 25,123
HTS_TST Sum of Test Result disaggregates 2015 25,123
HTS_TST Sum of Test Result disaggregates 2015 25,123
HTS_TST_POS By Test Result: Positive 2015 1,005
HTS_TST_POS By Test Result: Positive 2015 1,005
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 4
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 4
LAB_CAP Sum of Site Support Type disaggregates 2015 4
PMTCT_ARV Life-long ART (including Option B+) 2015 273
PMTCT_ARV Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 91
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 364
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 364
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 145
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 128
PMTCT_ARV Sum of New and Current disaggregates 2015 273
PMTCT_ARV Sum of Regimen Type disaggregates 2015 364
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 273
PMTCT_ARV_NGI Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 91
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 364
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 364
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 145
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 128
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 273
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 364
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 218
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 73
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 15
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 364
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 291
PMTCT_EID Sum of Infant Age disaggregates 2015 291
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 4
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 4
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 4
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 4
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 4
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 4
PMTCT_STAT By: Known positives at entry 2015 171
PMTCT_STAT By: Number of new positives identified 2015 193
PMTCT_STAT Number of new ANC and L&D clients 2015 4,379
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 4,379
PMTCT_STAT Sum of Positives Status disaggregates 2015 364
PMTCT_STAT_NGI By: Known positives at entry 2015 171
PMTCT_STAT_NGI By: Number of new positives identified 2015 193
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 4,379
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 4,379
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 364
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 3
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 4
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 3
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 3
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 4
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 4
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 4
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 4
SITE_SUPP Number of unique sites supported by PEPFAR 2015 4
TB_ART Age: 0-4 2015 5
TB_ART Age: 15+ 2015 166
TB_ART Age: 5-14 2015 12
TB_ART Aggregated Age: <15 2015 17
TB_ART Aggregated Age: 15+ 2015 166
TB_ART Female 2015 84
TB_ART Known HIV-positive 2015 73
TB_ART Male 2015 99
TB_ART Newly tested 2015 110
TB_ART Sum of Aggregated Age disaggregates 2015 183
TB_ART Sum of Sex disaggregates 2015 183
TB_ART Sum of Test Status disaggregates 2015 183
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 203
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 183
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 4
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 4
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 4
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 4
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 4
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 4
TB_SCREEN Age: <1 2015 12
TB_SCREEN Age: 1-4 2015 83
TB_SCREEN Age: 10-14 2015 114
TB_SCREEN Age: 15-19 2015 78
TB_SCREEN Age: 20-24 2015 260
TB_SCREEN Age: 25-49 2015 2,560
TB_SCREEN Age: 5-9 2015 147
TB_SCREEN Age: 50+ 2015 610
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 356
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 3,508
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 4,067
TB_SCREEN Sex: Female 2015 2,493
TB_SCREEN Sex: Male 2015 1,371
TB_SCREEN Sum of Age disaggregates 2015 434
TB_SCREEN Sum of Aggregated Age disaggregates 2015 3,864
TB_SCREEN Sum of Sex disaggregates 2015 3,864
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 3,864
TX_CURR Age/Sex: <1 Female 2015 4
TX_CURR Age/Sex: <1 Male 2015 4
TX_CURR Age/Sex: 1-4 Female 2015 29
TX_CURR Age/Sex: 1-4 Male 2015 29
TX_CURR Age/Sex: 15+ Female 2015 1,645
TX_CURR Age/Sex: 15+ Male 2015 885
TX_CURR Age/Sex: 5-14 Female 2015 92
TX_CURR Age/Sex: 5-14 Male 2015 92
TX_CURR Aggregated Age/Sex: <1 Female 2015 4
TX_CURR Aggregated Age/Sex: <1 Male 2015 4
TX_CURR Aggregated Age/Sex: <15 Female 2015 125
TX_CURR Aggregated Age/Sex: <15 Male 2015 125
TX_CURR Aggregated Age/Sex: 15+ Female 2015 1,645
TX_CURR Aggregated Age/Sex: 15+ Male 2015 885
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 2,780
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 65
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 64
TX_CURR Sum of age/sex disaggregates 2015 250
TX_CURR Sum of Aggregated Age/Sex <15 2015 250
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 2,530
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 2,780
TX_CURR_NGI Age/Sex: <1 Female 2015 4
TX_CURR_NGI Age/Sex: <1 Male 2015 4
TX_CURR_NGI Age/Sex: 1-4 Female 2015 29
TX_CURR_NGI Age/Sex: 1-4 Male 2015 29
TX_CURR_NGI Age/Sex: 15+ Female 2015 1,645
TX_CURR_NGI Age/Sex: 15+ Male 2015 885
TX_CURR_NGI Age/Sex: 5-14 Female 2015 92
TX_CURR_NGI Age/Sex: 5-14 Male 2015 92
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 4
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 4
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 125
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 125
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 1,645
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 885
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 2,780
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 2,780
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 250
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 2,530
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 2,780
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 1
TX_DIST Total number of PEPFAR supported District Health Offices 2015 1
TX_NEW Aggregated Grouping by Age: <1 Male 2015 14
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 14
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 47
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 47
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 368
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 199
TX_NEW Breastfeeding status 2015 13
TX_NEW By Age/Sex: <1 Female 2015 14
TX_NEW By Age/Sex: <1 Male 2015 14
TX_NEW By Age/Sex: 1-4 Female 2015 8
TX_NEW By Age/Sex: 1-4 Male 2015 8
TX_NEW By Age/Sex: 10-14 Female 2015 11
TX_NEW By Age/Sex: 10-14 Male 2015 11
TX_NEW By Age/Sex: 15-19 Female 2015 8
TX_NEW By Age/Sex: 15-19 Male 2015 5
TX_NEW By Age/Sex: 20-24 Female 2015 32
TX_NEW By Age/Sex: 20-24 Male 2015 9
TX_NEW By Age/Sex: 25-49 Female 2015 275
TX_NEW By Age/Sex: 25-49 Male 2015 138
TX_NEW By Age/Sex: 5-9 Female 2015 14
TX_NEW By Age/Sex: 5-9 Male 2015 14
TX_NEW By Age/Sex: 50+ Female 2015 53
TX_NEW By Age/Sex: 50+ Male 2015 47
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 661
TX_NEW Pregnancy status 2015 115
TX_NEW Sum of Age/Sex disaggregates 2015 661
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 661
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 14
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 517
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 38
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 52
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 517
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 569
TX_RET Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 227
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 670
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 17
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 608
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 45
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 62
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 608
TX_RET_den Pregnancy and breastfeeding status (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 267
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 3
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 4
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 3
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 3
TX_SITE Total number of PEPFAR-supported ART sites 2015 4
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 4
Cross Cutting Budget Categories and Known Amounts Total: $849,970
Human Resources for Health $782,470
Gender: Gender Based Violence (GBV) $33,750
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $33,750
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning